BC068157, a protein intricately involved in cellular processes, is associated with diverse functions, including angiogenesis, DNA repair, and cellular signaling. Functionally, BC068157 is implicated in regulating crucial aspects of cellular homeostasis, making it a key player in various cellular pathways. The general mechanisms of inhibition for BC068157 inhibitors involve targeted disruptions of specific molecular interactions or signaling pathways. For instance, Axitinib indirectly influences BC068157 by targeting VEGFR-mediated angiogenic signaling. By disrupting downstream events in angiogenesis, Axitinib indirectly modulates BC068157-associated cellular processes, illustrating the interconnected nature of angiogenic pathways and BC068157 function.
Furthermore, Nutlin-3 indirectly impacts BC068157 by disrupting the p53-MDM2 interaction, influencing BC068157 through alterations in MDM2-mediated cellular processes. This indirect modulation emphasizes the interconnectedness of protein-protein interactions and BC068157-associated pathways. Dasatinib, by targeting Src kinase, indirectly influences BC068157-associated signaling events, illustrating its indirect impact on BC068157 by disrupting specific protein-protein interactions within kinase pathways. In addition, Wortmannin, a PI3K inhibitor, indirectly inhibits BC068157 by disrupting the PI3K/AKT pathway. This disruption affects BC068157-associated cellular processes and downstream signaling events, highlighting the interconnected nature of kinase pathways and the indirect modulation of BC068157 by Wortmannin. Epigenetic modulators like GSK-J4 and Trichostatin A directly influence BC068157 by modulating histone demethylation and acetylation, respectively. These actions on chromatin structure directly affect BC068157-mediated gene regulation, emphasizing the role of epigenetic modifications in BC068157-associated cellular processes. The diverse mechanisms of inhibition collectively illustrate the complexity of BC068157's involvement in cellular processes and offer insights into potential avenues for targeted interventions in various pathways.
SEE ALSO...
Items 161 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|